PARP inhibition potentiates the cytotoxic activity of C-1305, a selective inhibitor of topoisomerase II, in human BRCA1-positive breast cancer cells()

por Węsierska-Gądek, Józefa, Zulehner, Nora, Ferk, Franziska, Składanowski, Andrzej, Komina, Oxana, Maurer, Margarita
Publicado 2012